Researchers identify genetic factors that contribute to Alzheimer's disease

January 3, 2018, Boston University School of Medicine

Researchers have identified several new genes responsible for Alzheimer's disease (AD) including those leading to functional and structural changes in the brain and elevated levels of AD proteins in cerebrospinal fluid (CSF).

Unlike traditional AD research, this study focused on individual groups across specific on the cognitive spectrum [normal cognitive functioning or controls, (MCI) and AD cases]. As opposed to the typical study design which combines all such persons into a single group or focuses only on cognitively healthy persons, this research identified several novel genetic associations within multiple subgroups.

According to the researchers these associations are not evident when comparing AD cases to controls or within AD cases, suggesting that these signals underlie processes before onset of AD. As such, these may be more attractive targets for drug development because it is increasingly recognized that effective drugs will be those given to persons before or shortly after they develop cognitive impairment.

The researchers tested the association between AD-related brain MRI measures, logical memory test scores and CSF levels of two AD proteins (amyloid-beta and tau) with several million genetic markers (called SNPs) across the genome in a sample of 1,189 participants of the Alzheimer Disease Neuroimaging Initiative (ADNI) study. They then examined the biological significance of the top-ranked associated SNPs and genes using several datasets containing information about gene expression in parts of the brain most affected by AD.

Two of the study-wide significant genes identified in the normal cognitive functioning group, SRRM4 and MTUS1, are involved in neuronal signaling, development and loss. Another gene identified in this group, GRIN2B, encodes a subunit of a receptor that has roles in resilience of neurons and memory.

"Our findings provide important insight about biological mechanisms leading to Alzheimer disease, especially at stages of the disease before symptoms occur," says Lindsay A. Farrer, PhD, Distinguished Professor of Genetics and Chief of the Biomedical Genetics section at Boston University School of Medicine, and principal investigator of the study. "The novel genes we identified may be potential targets for developing new treatments that might delay or even prevent onset of symptoms of this insidious disease."

Explore further: Memory scores limited as Alzheimer's screening tool

Related Stories

Memory scores limited as Alzheimer's screening tool

December 4, 2017
(HealthDay)—Low memory scores are an early marker of amyloid positivity, but have limited value as a screening measure for early Alzheimer's disease among persons without dementia, according to a study published online ...

Study finds genes associated with hippocampal atrophy

June 28, 2012
In a genome-wide association (GWA) study, researchers from Boston University Schools of Medicine (BUSM) and Public Health (BUSPH) have identified several genes which influence degeneration of the hippocampus, the part of ...

A protein involved in Alzheimer's disease may also be implicated in cognitive abilities in children

August 2, 2017
Rare mutations in the amyloid precursor protein (APP) have previously been shown to be strongly associated with Alzheimer's disease (AD). Common genetic variants in this protein may also be linked to intelligence (IQ) in ...

Two Alzheimer's risk genes linked to brain atrophy, promise future blood markers

December 23, 2015
Two genetic variants previously linked to Alzheimer's disease have been more specifically tied to brain atrophy that is characteristic of the disease.

Investigating plasma levels as a biomarker for Alzheimer's disease

April 18, 2016
A Centre for Healthy Brain Ageing (CHeBA) paper published in Current Alzheimer Research presents the first detailed study of the relationship between plasma levels of two amyloid beta peptides (Aβ1-40 and Aβ1-42), brain ...

A step forward searching for an early biomarker of Alzheimer's disease

July 19, 2016
Researchers from Centre for Biomedical Technology (CTB) at Universidad Politécnica de Madrid (UPM) have shown that the abnormal pattern of functional connectivity in patients with mild cognitive impairment can be considered ...

Recommended for you

Machine learning uncovers dementia subtypes with implication for drug trials

October 22, 2018
Machine learning could help to find new treatments for dementia, according to researchers at UCL.

Losing control of gene activity in Alzheimer's disease

October 22, 2018
Pioneering research into the mechanisms controlling gene activity in the brain could hold the key to understanding Alzheimer's disease and might help identify effective treatments in the future.

Deep brain stimulation not effective for treating early Alzheimer's

October 22, 2018
A new study from Johns Hopkins shows that individuals with early onset Alzheimer's disease—those under the age of 65—don't benefit from deep brain stimulation, a treatment already proven to be effective for easing motor ...

Hypothesis underpinning dementia research 'flawed'

October 16, 2018
A hypothesis which has been the standard way of explaining how the body develops Alzheimer's Disease for almost 30 years is flawed, according to a University of Manchester biologist.

Study suggests biological basis for depression, anxiety, sleep disturbances in older adults

October 15, 2018
UC San Francisco researchers, in collaboration with the unique Brazilian Biobank for Aging Studies (BBAS) at the University of São Paulo, have shown that the earliest stages of the brain degeneration associated with Alzheimer's ...

Many cases of dementia may arise from non-inherited DNA 'spelling mistakes'

October 15, 2018
Only a small proportion of cases of dementia are thought to be inherited—the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications, a team of scientists led by researchers ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.